At a glance
ClinicalIndex Comparison RecordN/ACompleted· 122 enrolled
Drug / intervention
Opti-Free® PureMoist® contact lens solution +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Study of OPTI-FREE® PureMoist® for Presbyopic Contact Lens Wearers
In Brief
A clinical study evaluating Opti-Free® PureMoist® contact lens solution, Habitual Multi-Purpose Contact Lens Solution, and 1 other intervention for Presbyopia. Completed, enrolled 122 participants.
Detailed Summary
The purpose of this study is to evaluate OPTI-FREE® PureMoist® (OFPM) compared to non-HYDRAGLYDE® multi-purpose contact lens solutions in presbyopes currently wearing soft contact lenses and experiencing symptoms of dryness.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPresbyopia
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedNov 2016
Enrollment StartDec 2016
Primary CompletionApr 2017
TodayJul 2026
First PostedNov 17, 2016
Enrollment StartDec 16, 2016
Primary CompletionApr 1, 2017
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 9.6 years ago
Interventions
Opti-Free® PureMoist® contact lens solutiondevice
Habitual Multi-Purpose Contact Lens Solutiondevice
Habitual Contact Lensesdevice
Subject's habitual contact lens brand worn in a daily wear modality for 30 days.